Generic name: conjugated estrogens
Dosage form: tablet, film coated
This dosage information does not include all the information needed to use Premarin safely and effectively. See full prescribing information for Premarin.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
When estrogen therapy is prescribed for a postmenopausal woman with a uterus, progestin should also be initiated to reduce the risk of endometrial cancer. A woman without a uterus does not need progestin. Use of estrogen-alone, or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Patients should be reevaluated periodically as clinically appropriate (for example at 3-month to 6-month intervals) to determine if treatment is still necessary. Adequate diagnostic measures, such as directed or random endometrial sampling, when indicated, should be undertaken to rule out malignancy in postmenopausal women with undiagnosed persistent or recurring abnormal genital bleeding.
- Premarin Side Effects
- Premarin Drug Interactions
- Premarin (conjugated estrogens) consumer information
- Cenestin (synthetic conjugated estrogens) tablet, film coated dosage information
- Conjugated Estrogens dosage information
- Enjuvia (synthetic conjugated estrogens, b) tablet dosage information
- Enjuvia (conjugated estrogens) consumer information
- Premarin Injection (conjugated estrogens) injection, powder, lyophilized, for solution dosage information